CA2652558A1 - Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches - Google Patents

Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches Download PDF

Info

Publication number
CA2652558A1
CA2652558A1 CA002652558A CA2652558A CA2652558A1 CA 2652558 A1 CA2652558 A1 CA 2652558A1 CA 002652558 A CA002652558 A CA 002652558A CA 2652558 A CA2652558 A CA 2652558A CA 2652558 A1 CA2652558 A1 CA 2652558A1
Authority
CA
Canada
Prior art keywords
coli
dna
bacterial
composition
database
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002652558A
Other languages
English (en)
Inventor
Andrew K. Benson
Robert A. Hoerr
Eileen F. Bostwick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
BioBalance LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioBalance LLC filed Critical BioBalance LLC
Publication of CA2652558A1 publication Critical patent/CA2652558A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002652558A 2006-05-18 2007-05-09 Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches Abandoned CA2652558A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80109806P 2006-05-18 2006-05-18
US60/801,098 2006-05-18
PCT/US2007/011200 WO2007136553A2 (fr) 2006-05-18 2007-05-09 Souches bactériennes, compositions les contenant et utilisation probiotique de ces souches

Publications (1)

Publication Number Publication Date
CA2652558A1 true CA2652558A1 (fr) 2007-11-29

Family

ID=38647934

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002652558A Abandoned CA2652558A1 (fr) 2006-05-18 2007-05-09 Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches

Country Status (4)

Country Link
EP (1) EP2035544A2 (fr)
JP (1) JP2009537138A (fr)
CA (1) CA2652558A1 (fr)
WO (1) WO2007136553A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2531971T3 (es) 2004-02-03 2015-03-23 Prevtec Microbia Inc. Uso de bacterias vivas para fomentar el crecimiento en animales
JP5214464B2 (ja) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2008076975A1 (fr) 2006-12-18 2008-06-26 Advanced Bionutrition Corporation Produit alimentaire sec contenant un probiotique vivant
CA2986751A1 (fr) 2009-03-27 2010-09-30 Intervet International B.V. Vaccins microparticulaires utilisables pour proceder a une vaccination et a des rappels par voie orale ou nasale chez les animaux, dont les poissons
GB0922467D0 (en) * 2009-04-24 2010-02-03 Danisco Feed supplement
JP5841527B2 (ja) * 2009-05-26 2016-01-13 アドバンスド バイオニュートリション コーポレーション 生物学的に活性な微生物および／または生物活性材料を含む安定な乾燥粉末組成物およびその製造方法
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN102725393B (zh) 2010-01-28 2015-12-02 先进生物营养公司 包含生物活性材料的干燥玻璃质组合物
SG187250A1 (en) 2010-08-13 2013-03-28 Advanced Bionutrition Corp Dry storage stabilizing composition for biological materials
AU2011253984A1 (en) 2010-12-07 2012-06-28 Biobalance Llc Method For Identifying E. Coli M-17
CN102653779B (zh) * 2011-03-04 2014-02-19 北京科润三联生物技术有限责任公司 一种新型重组抗菌多肽药物的制备方法
KR101794242B1 (ko) * 2011-06-07 2017-11-07 임병갑 서방성 경구용 액상 제제
EP2732024B1 (fr) * 2011-07-13 2017-03-01 Foodchek Systems, Inc. Milieu de culture, procédé de culture de listeria et procédé de détection de listeria
CN103131724B (zh) * 2011-11-25 2015-02-25 畿晋庆三联（北京）生物技术有限公司 一种高效表达工程菌重组蛋白的方法及应用
CN104955466A (zh) * 2012-11-23 2015-09-30 赛里斯治疗公司 协同细菌组合物和其制造方法和用途
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3904502A3 (fr) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions et procédés
JP6479685B2 (ja) 2013-02-04 2019-03-06 セレス セラピューティクス インコーポレイテッド 病原性細菌生育の抑制のための組成物および方法
CA2906921A1 (fr) 2013-03-15 2014-09-18 Seres Therapeutics, Inc. Compositions microbiennes et procedes associes bases sur un reseau
JP6833514B2 (ja) 2013-11-25 2021-02-24 セレス セラピューティクス インコーポレイテッド 相乗作用のある細菌組成物ならびにその製造及び使用方法
WO2015095241A2 (fr) 2013-12-16 2015-06-25 Seres Health, Inc. Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
DK3328215T3 (da) 2015-07-29 2021-09-13 Advanced Bionutrition Corp Stabilt tørre probiotiske sammensætninger til særlige kostanvendelser
EP3668527A1 (fr) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions et méthodes de traitement de la maladie cholestatique
JP7252606B2 (ja) * 2019-03-25 2023-04-05 国立研究開発法人農業・食品産業技術総合研究機構 乳酸菌検出プライマーセットおよび該プライマーセットを用いた検出方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Also Published As

Publication number Publication date
WO2007136553A3 (fr) 2008-01-31
EP2035544A2 (fr) 2009-03-18
JP2009537138A (ja) 2009-10-29
WO2007136553A2 (fr) 2007-11-29

Similar Documents

Publication Publication Date Title
CA2652558A1 (fr) Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches
US11458174B2 (en) Synergistic bacterial compositions and methods of production and use thereof
US20230226126A1 (en) Synergistic Bacterial Compositions and Methods of Production and Use Thereof
Rozman et al. Characterization of antimicrobial resistance in lactobacilli and bifidobacteria used as probiotics or starter cultures based on integration of phenotypic and in silico data
US10610549B2 (en) Composition comprising bacterial strains
JP6833514B2 (ja) 相乗作用のある細菌組成物ならびにその製造及び使用方法
Rosander et al. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938
RU2664479C2 (ru) Композиции и способы
Pérez et al. Diarrheagenic Escherichia coli in children from Costa Rica
KR20210100662A (ko) 박테리아를 안정화시키는 조성물 그리고 이의 용도
Bajorek et al. B. infantis EVC001 is well-tolerated and improves human milk oligosaccharide utilization in preterm infants in the neonatal intensive care unit
Orth et al. Prevalence, structure and expression of urease genes in Shiga toxin-producing Escherichia coli from humans and the environment
El‐Sharoud et al. Molecular characterisation and stress tolerance of E scherichia coli isolated from dairy and dried milk‐related products
Sato et al. Development of strain-specific PCR primers for quantitative detection of Bacillus mesentericus strain TO-A in human feces
Abdulmajeed et al. Isolation and Identification of E. Coli O157: H7 Strains Among Diarrheal Sample in Relation with the Presence of Stx1, Stx2, Hlya and Eaea Genes
Konstantinov Lactobacilli in the porcine intestine: from composition to functionality
Jayaweera et al. Prevalence of Salmonella Pathogenisity Island (SPI1, SPI2, SPI3 and SPI5) Genes in Salmonella species Isolated from fresh Broiler Chicken Meat in Sri Lanka.
WO2024062208A1 (fr) Compositions et méthodes de réduction du sulfure endogène chez des patients atteints de maladies inflammatoires de l'intestin
Abed et al. Detection of Diarrhoeagenic Escherichia Coli Among Other Bacterial Species Isolated from Children Patients by Automated Methods and Culture based Techniques
WO2023039645A1 (fr) Isolats d'enterococcus biothérapeutiques
Munns Characterization of Escherichia coli O157: H7 from super-shedding feedlot cattle
Lienemann Foodborne human isolates of Salmonella and Shiga toxin-producing Escherichia coli of domestic origin in Finland
Tu et al. Genomic characteristics of the Campylobacter fetus sap island
Temmerman Culture-dependent and culture-independent microbial analysis of probiotics
Boyle et al. 31 Safety Assessment of Probiotics

Legal Events

Date Code Title Description
FZDE Dead